PRESS RELEASES 2016

Jai Patel appointed as Chief Medical Officer and Roger J. Garceau elected to the Board New York and Paris, December 9, 2016 Enterome SA a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce the appointments of Jai Patel, Ph.D. as Chief... read more →

Paris, France and Cambridge, MA, USA – September 19, 2016 Enterome Bioscience SA (“Enterome”), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce that it has appointed Christophe Bonny, Ph.D. as Chief Scientific Officer (CSO). Dr. Bonny, will be responsible for... read more →

New York and Paris, November 16, 2016 Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets... read more →

Paris, France and Cambridge, MA, USA – May 19, 2016 Enterome Bioscience SA (“Enterome”), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce that it has opened a new office in Cambridge, MA to support its operations and corporate development activities... read more →

Paris, France and Boston, MA – April 20 2016 ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnosticsbased on the gut microbiome, announces that it has raised €14.5 million in a Series C financing round. The round was led by existing investors, such as Seventure (including from... read more →

Paris, France and Boston, MA – April 18 2016 ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, has signed an exclusive worldwide license agreement with Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) to research, develop and commercialize novel small molecule FimH antagonists for... read more →

Paris, France and Boston, MA – April 13, 2016 ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that Pierre Bélichard, its Chief Executive Officer, will participate at the following conferences: FBR Healthcare Series: New Prescriptions: Innovation in the Treatment of... read more →

Paris, France and Boston, MA, USA – January 7, 2016 Enterome Bioscience SA announces that it has entered into a collaborative research agreement with Janssen Biotech, Inc. (Janssen Biotech), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the French National Institute for Agriculture Research (INRA). Read the... read more →

Osaka, Japan, Paris, France and Boston, MA, USA — January 6, 2016 Takeda Pharmaceutical Company Ltd. and Enterome Bioscience SA today announced they have entered into a strategic drug discovery collaboration to research and develop potential new therapeutics directed at microbiome targets thought to play crucial roles in gastrointestinal disorders,... read more →